Literature DB >> 5581118

Active immunotherapy of mouse RC 19 and E female K1 leukaemias applied after the intravenous transplantation of the tumour cells.

G Mathé, P Pouillart, F Lapeyraque.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5581118     DOI： 10.1007/BF02137303

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  5 in total

1.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

2.  [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].

Authors:  G Mathé
Journal:  Rev Fr Etud Clin Biol       Date:  1968-11

3.  [Use of the cytotoxicity inhibition test for the determination of graft antigens in vitro in mice].

Authors:  R Motta
Journal:  Rev Fr Etud Clin Biol       Date:  1968 Aug-Sep

4.  [Demonstration of the efficacy of active immunotherapy in human acute lymphoblastic leukemia].

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F de Vassal
Journal:  Rev Fr Etud Clin Biol       Date:  1968-05

5.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.